New York Health Care Inc. (BBAL) Financials Nov 3,
Post# of 250675
Posted On: 11/17/2014 3:41:36 AM
New York Health Care Inc. (BBAL) Financials Nov 3, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for New York Health Care Inc.
Fiscal year is January-December. All values USD millions. 2003 2004 2005 2006 2007 5-year trend
Sales/Revenue 45.06M 42.29M 44.72M 45.56M 44.4M
Cost of Goods Sold (COGS) incl. D&A 36.71M 35.6M 37.73M 37.42M 37.03M
COGS excluding D&A 36.11M 34.78M 37.08M 36.75M 36.63M
Depreciation & Amortization Expense 606,747 819,887 652,152 672,584 404,622
Depreciation 129,718 50,389 50,002 52,523 40,000
Amortization of Intangibles 477,029 769,498 602,150 620,061 364,622
Gross Income 8.35M 6.69M 6.99M 8.14M 7.37M
2003 2004 2005 2006 2007 5-year trend
SG&A Expense 12.54M 11.17M 16.08M 11M 7.8M
Research & Development 1.24M 1.06M 2.8M 1.64M 648,759
Other SG&A 11.3M 10.12M 13.28M 9.36M 7.15M
Other Operating Expense 0 0 0 0 0
Unusual Expense 17.87M 1.74M 0 926,322 788,632
EBIT after Unusual Expense (17.87M) (1.74M) 0 (926,322) (788,632)
Non Operating Income/Expense 0 0 0 0 193,815
Non-Operating Interest Income 51,255 69,877 89,108 164,969 77,893
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 2,173 29,538 24,135 61,394 29,066
Gross Interest Expense 2,173 29,538 24,135 61,394 29,066
Interest Capitalized 0 0 0 0 0
Pretax Income (22.01M) (6.19M) (9.03M) (3.68M) (977,724)
Income Tax 39,000 (67,176) 78,628 75,120 74,627
Income Tax - Current Domestic 39,000 (67,176) 78,628 75,120 -
Income Tax - Current Foreign 0 - - 0 0
Income Tax - Deferred Domestic 0 - - 0 0
Income Tax - Deferred Foreign 0 - - 0 0
Income Tax Credits 0 - - 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (22.05M) (6.12M) (9.1M) (3.76M) (1.05M)
Minority Interest Expense 0 0 0 0 0
Net Income (22.05M) (6.12M) (9.1M) (3.76M) (1.05M)
Extraordinaries & Discontinued Operations 0 48,968 2.78M 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 2.78M 0 0
Cumulative Effect - Accounting Chg 0 - - 0 0
Discontinued Operations 0 48,968 - 0 0
Net Income After Extraordinaries (22.05M) (6.07M) (6.32M) (3.76M) (1.05M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (22.05M) (6.12M) (9.1M) (3.76M) (1.05M)
EPS (Basic) (0.91) (0.24) (0.29) (0.11) (0.03)
Basic Shares Outstanding 24.28M 24.94M 31.9M 33.25M 33.54M
EPS (Diluted) (0.91) (0.24) (0.29) (0.11) (0.03)
Diluted Shares Outstanding 24.28M 24.94M 31.9M 33.25M 33.54M
EBITDA (3.59M) (3.67M) (8.44M) (2.19M) (27,112)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for New York Health Care Inc.
Fiscal year is January-December. All values USD millions. 2003 2004 2005 2006 2007 5-year trend
Sales/Revenue 45.06M 42.29M 44.72M 45.56M 44.4M
Cost of Goods Sold (COGS) incl. D&A 36.71M 35.6M 37.73M 37.42M 37.03M
COGS excluding D&A 36.11M 34.78M 37.08M 36.75M 36.63M
Depreciation & Amortization Expense 606,747 819,887 652,152 672,584 404,622
Depreciation 129,718 50,389 50,002 52,523 40,000
Amortization of Intangibles 477,029 769,498 602,150 620,061 364,622
Gross Income 8.35M 6.69M 6.99M 8.14M 7.37M
2003 2004 2005 2006 2007 5-year trend
SG&A Expense 12.54M 11.17M 16.08M 11M 7.8M
Research & Development 1.24M 1.06M 2.8M 1.64M 648,759
Other SG&A 11.3M 10.12M 13.28M 9.36M 7.15M
Other Operating Expense 0 0 0 0 0
Unusual Expense 17.87M 1.74M 0 926,322 788,632
EBIT after Unusual Expense (17.87M) (1.74M) 0 (926,322) (788,632)
Non Operating Income/Expense 0 0 0 0 193,815
Non-Operating Interest Income 51,255 69,877 89,108 164,969 77,893
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 2,173 29,538 24,135 61,394 29,066
Gross Interest Expense 2,173 29,538 24,135 61,394 29,066
Interest Capitalized 0 0 0 0 0
Pretax Income (22.01M) (6.19M) (9.03M) (3.68M) (977,724)
Income Tax 39,000 (67,176) 78,628 75,120 74,627
Income Tax - Current Domestic 39,000 (67,176) 78,628 75,120 -
Income Tax - Current Foreign 0 - - 0 0
Income Tax - Deferred Domestic 0 - - 0 0
Income Tax - Deferred Foreign 0 - - 0 0
Income Tax Credits 0 - - 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (22.05M) (6.12M) (9.1M) (3.76M) (1.05M)
Minority Interest Expense 0 0 0 0 0
Net Income (22.05M) (6.12M) (9.1M) (3.76M) (1.05M)
Extraordinaries & Discontinued Operations 0 48,968 2.78M 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 2.78M 0 0
Cumulative Effect - Accounting Chg 0 - - 0 0
Discontinued Operations 0 48,968 - 0 0
Net Income After Extraordinaries (22.05M) (6.07M) (6.32M) (3.76M) (1.05M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (22.05M) (6.12M) (9.1M) (3.76M) (1.05M)
EPS (Basic) (0.91) (0.24) (0.29) (0.11) (0.03)
Basic Shares Outstanding 24.28M 24.94M 31.9M 33.25M 33.54M
EPS (Diluted) (0.91) (0.24) (0.29) (0.11) (0.03)
Diluted Shares Outstanding 24.28M 24.94M 31.9M 33.25M 33.54M
EBITDA (3.59M) (3.67M) (8.44M) (2.19M) (27,112)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)